3/25/2014 7:08:23 AM
Sanofi, maker of the world’s top-selling diabetes treatment, has joined the bidding for Merck & Co.’s over-the-counter health-products unit, people with knowledge of the matter said. Final bids, which could value the maker of Coppertone sunblock and Claritin allergy medicine at $10 billion to $12 billion, are due next week, two people said, asking not to be identified discussing private information. Reckitt Benckiser Group Plc, which sells Clearasil acne treatment cream, is the most aggressive bidder making it the frontrunner for the business, three people said.
Help employers find you! Check out all the jobs and post your resume.
comments powered by